- Home
- CETY vs IGC Comparison
CETY vs IGC Comparison
Compare CETY & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETY
- IGC
- Stock Information
- Founded
- CETY 1993
- IGC 2005
- Country
- CETY United States
- IGC United States
- Employees
- CETY N/A
- IGC N/A
- Industry
- CETY Power Generation
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- CETY Utilities
- IGC Health Care
- Exchange
- CETY Nasdaq
- IGC Nasdaq
- Market Cap
- CETY 27.7M
- IGC 29.4M
- IPO Year
- CETY N/A
- IGC N/A
- Fundamental
- Price
- CETY $0.49
- IGC $0.34
- Analyst Decision
- CETY
- IGC Strong Buy
- Analyst Count
- CETY 0
- IGC 2
- Target Price
- CETY N/A
- IGC $3.75
- AVG Volume (30 Days)
- CETY 90.9K
- IGC 387.6K
- Earning Date
- CETY 11-19-2024
- IGC 02-12-2025
- Dividend Yield
- CETY N/A
- IGC N/A
- EPS Growth
- CETY N/A
- IGC N/A
- EPS
- CETY N/A
- IGC N/A
- Revenue
- CETY $11,779,593.00
- IGC $1,183,000.00
- Revenue This Year
- CETY N/A
- IGC N/A
- Revenue Next Year
- CETY N/A
- IGC $13.38
- P/E Ratio
- CETY N/A
- IGC N/A
- Revenue Growth
- CETY 119.20
- IGC N/A
- 52 Week Low
- CETY $0.45
- IGC $0.27
- 52 Week High
- CETY $2.39
- IGC $0.91
- Technical
- Relative Strength Index (RSI)
- CETY 37.13
- IGC 44.69
- Support Level
- CETY $0.45
- IGC $0.31
- Resistance Level
- CETY $0.60
- IGC $0.36
- Average True Range (ATR)
- CETY 0.05
- IGC 0.02
- MACD
- CETY 0.00
- IGC -0.00
- Stochastic Oscillator
- CETY 21.11
- IGC 42.71
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business, as well as continuing to support other emerging growth companies with their Clean-tech technologies. It has four segments: Clean Energy HRS & CETY Europe, CETY HK, CETY Renewables and Electronic Manufacturing. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.